Clinical Trials on 狄诺塞麦 vs 唑来膦酸盐 in United States
总计506个结果
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)撤销
-
Ann & Robert H Lurie Children's Hospital of Chicago完全的
-
Jennifer E. SchwartzMillennium Pharmaceuticals, Inc.完全的
-
Dana-Farber Cancer Institute招聘中
-
National Cancer Institute (NCI)招聘中闭塞性细支气管炎综合征 | 慢性移植物抗宿主病 | 慢性移植物抗宿主病美国
-
National Cancer Institute (NCI)主动,不招人
-
Ohio State University Comprehensive Cancer Center招聘中
-
National Cancer Institute (NCI)完全的Chronic Graft-Versus-Host-Disease美国
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
University of California, San Diego完全的Telemedicine Evaluation vs Telephone Evaluation美国
-
University of FloridaAmerican Cancer Society, Inc.完全的
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)终止
-
Ronald Paquette招聘中
-
Dana-Farber Cancer InstituteAstellas Pharma Inc; Brigham and Women's Hospital终止
-
University of Alabama at BirminghamMemorial Sloan Kettering Cancer Center主动,不招人
-
National Heart, Lung, and Blood Institute (NHLBI)New York University and New York Genome Center招聘中
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; Millennium Pharmaceuticals, Inc.完全的
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital完全的
-
Michigan Cornea Consultants, PCKresge Eye Institute完全的
-
Dana-Farber Cancer Institute招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
Dana-Farber Cancer Institute终止
-
National Cancer Institute (NCI)招聘中
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); Blood and Marrow Transplant Clinical Trials Network完全的
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb完全的
-
Mallinckrodt完全的
-
Oncoimmune, Inc., a subsidiary of Merck & Co.,...National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio State University 和其他合作者完全的Efprezimod Alfa (CD24Fc, MK-7110) 用于预防清髓性同种异体造血干细胞移植 (HSCT) 后急性移植物抗宿主病 (GVHD) 的 II 期试验 (MK-7110-002)白血病 | 造血干细胞移植 | 移植物抗宿主病美国
-
Pavan Reddy, MD完全的
-
Ann & Robert H Lurie Children's Hospital of ChicagoAstex Pharmaceuticals, Inc.完全的
-
Spectrum Health HospitalsMillennium Pharmaceuticals, Inc.完全的
-
Nelson ChaoNational Center for Advancing Translational Sciences (NCATS); Mereo BioPharma撤销
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Institutes of Health (NIH)完全的
-
Massachusetts General HospitalAmerican Cancer Society, Inc.完全的
-
MallinckrodtParexel完全的